Accelerating Pharma Innovation: How Unified Observability Powers IT Efficiency

In the fast-paced world of pharmaceuticals, every second counts. When it comes to bringing lifesaving drugs to market, scientists and research technicians must feel confident that the tools they use daily are helping them accelerate (and not slow down) progress.

From clinical trials to delivering breakthrough medicines, R&D is the heartbeat of the industry. However, technology challenges can affect productivity, reputation, and ultimately, patient outcomes.

To drive long-term sustainable growth, leading pharmaceutical companies are diving into unified observability: bringing together data, insights, and actions to enable IT teams to improve the digital experience for scientists and technicians. Because time saved is time invested.

Create more time for R&D 

Optimizing the digital experience is imperative for scientific research programs. If lab technicians can’t access their LIMS or bioinformatics tools when they need to, research activities are delayed, increasing R&D downtime and impacting operations.

With unified observability, companies improve as much as 58% their application log-in times and provide a digital experience that gives time back to scientists, while IT teams can ensure that every second saved is a second invested in pushing the boundaries of scientific discovery. 

Unlock revenue potential from business-critical IT systems 

By strategically optimizing their IT environment, pharmaceutical companies can minimize errors, improve application performance, and unlock the full potential of their systems. This optimization leads to streamlined operations and increased productivity across the business.

Ultimately, allowing staff to do what they do best, pharmaceutical companies accelerate the delivery of drugs into the hands of patients, which translates into tangible revenue growth.

Allow your IT teams to focus on high-value projects 

Investing in automated, AI-driven remediation solutions becomes paramount in the shift from transactional to transformational IT. Technical teams can move past doing repetitive tasks to focusing on value-added projects that keep high-performing talent happy and productive.

With up to 70% reduction in MTTR for service desk professionals, unified observability allows pharmaceutical companies to focus on the adoption of new technologies, research, and development processes to improve business and advance growth.

Build brand trust by reducing risk and focusing on quality and sustainability 

There is a need for pharma teams to drive greater focus on consumer experience and communication to avoid loss of influence and authority. Protecting the business against risks through data integrity and a resilient technology foundation is not an option–it’s a necessity.

In addition, increased focus on environmental sustainability and supply chain optimization has become an integral part of all leading pharmaceutical companies. Unified observability allows IT teams to become a part of the solution, by monitoring CO2 emissions from IT assets, as well as implementing smart device refreshes to reduce unnecessary waste, and lowering energy consumption from egress traffic in cloud-based systems.

Unlock the future of Pharma 

In the quest for innovation and efficiency, Riverbed Unified Observability is fueling digital transformation for pharmaceutical companies. It is not just about improving IT infrastructure; it’s about empowering scientists, technicians, and every individual contributing to R&D. Time is money, and with Riverbed Unified Observability, every moment saved is an investment in the future of pharmaceutical excellence. To explore how Riverbed can transform your IT environment and elevate your business, learn more here.